Puma Biotechnology - 48 Year Dividend Yield History | PBYI
Historical dividend payout and yield for Puma Biotechnology (PBYI) since 1971. The current TTM dividend payout for Puma Biotechnology (PBYI) as of February 15, 2019 is $0.00. The current dividend yield for Puma Biotechnology as of February 15, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the acquisition, in-licensing, development and commercialization of novel therapeutics for the treatment of cancer. Its products under development include PB272 (oral neratinib) for the treatment of patients with human epidermal growth factor receptor type 2 (HER2) positive metastatic breast cancer and gastric cancer and PB272 (neratinib intravenous) for the treatment of patients with advanced cancer. Puma Biotechnology, Inc. is headquartered in Los Angeles, California.